132 related articles for article (PubMed ID: 38477411)
1. Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy.
Li Y; Liu J; Chen Y; Weichselbaum RR; Lin W
Adv Sci (Weinh); 2024 Jun; 11(23):e2310309. PubMed ID: 38477411
[TBL] [Abstract][Full Text] [Related]
2. Carrier-Free Self-Assembly Nano-Sonosensitizers for Sonodynamic-Amplified Cuproptosis-Ferroptosis in Glioblastoma Therapy.
Zhu Y; Niu X; Ding C; Lin Y; Fang W; Yan L; Cheng J; Zou J; Tian Y; Huang W; Huang W; Pan Y; Wu T; Chen X; Kang D
Adv Sci (Weinh); 2024 Jun; 11(23):e2402516. PubMed ID: 38582500
[TBL] [Abstract][Full Text] [Related]
3. Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes.
Gao Y; Jin F; Zhang P; Zheng C; Zheng X; Xie J; Lu Y; Tong X; Du J; Zhang J; Wang Y
Biomed Pharmacother; 2024 Jun; 175():116727. PubMed ID: 38733771
[TBL] [Abstract][Full Text] [Related]
4. Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy.
Lu X; Chen X; Lin C; Yi Y; Zhao S; Zhu B; Deng W; Wang X; Xie Z; Rao S; Ni Z; You T; Li L; Huang Y; Xue X; Yu Y; Sun W; Shen X
Adv Sci (Weinh); 2024 May; 11(18):e2309984. PubMed ID: 38430531
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer.
Wang W; Lu K; Jiang X; Wei Q; Zhu L; Wang X; Jin H; Feng L
J Exp Clin Cancer Res; 2023 Jun; 42(1):142. PubMed ID: 37277863
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application.
Liu N; Chen M
Biomed Pharmacother; 2024 Feb; 171():116115. PubMed ID: 38181713
[TBL] [Abstract][Full Text] [Related]
7. Stimulus-Responsive Copper Complex Nanoparticles Induce Cuproptosis for Augmented Cancer Immunotherapy.
Hu F; Huang J; Bing T; Mou W; Li D; Zhang H; Chen Y; Jin Q; Yu Y; Yang Z
Adv Sci (Weinh); 2024 Apr; 11(13):e2309388. PubMed ID: 38269649
[TBL] [Abstract][Full Text] [Related]
8. Copper-coordinated nanoassemblies based on photosensitizer-chemo prodrugs and checkpoint inhibitors for enhanced apoptosis-cuproptosis and immunotherapy.
Liang W; Han C; Zhang D; Liu C; Zhu M; Xu F; Fang C; Zhang S; Liu C; Li Y
Acta Biomater; 2024 Feb; 175():341-352. PubMed ID: 38122883
[TBL] [Abstract][Full Text] [Related]
9. Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade.
Li Q; Wang Y; Jia W; Deng H; Li G; Deng W; Chen J; Kim BYS; Jiang W; Liu Q; Liu J
Clin Cancer Res; 2020 Apr; 26(7):1712-1724. PubMed ID: 31848190
[TBL] [Abstract][Full Text] [Related]
10. Engineered Microbial Nanohybrids for Tumor-Mediated NIR II Photothermal Enhanced Ferroptosis/Cuproptosis and Immunotherapy.
Ruan Y; Zhuang H; Zeng X; Lin L; Wang X; Xue P; Xu S; Chen Q; Yan S; Huang W
Adv Healthc Mater; 2024 Feb; 13(4):e2302537. PubMed ID: 37742322
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis.
Zhang P; Zhou C; Ren X; Jing Q; Gao Y; Yang C; Shen Y; Zhou Y; Hu W; Jin F; Xu H; Yu L; Liu Y; Tong X; Li Y; Wang Y; Du J
Redox Biol; 2024 Feb; 69():103007. PubMed ID: 38150993
[TBL] [Abstract][Full Text] [Related]
12. Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer Immunotherapy.
Guo B; Yang F; Zhang L; Zhao Q; Wang W; Yin L; Chen D; Wang M; Han S; Xiao H; Xing N
Adv Mater; 2023 Jun; 35(22):e2212267. PubMed ID: 36916030
[TBL] [Abstract][Full Text] [Related]
13. A biomimetic cuproptosis amplifier for targeted NIR-II fluorescence/photoacoustic imaging-guided synergistic NIR-II photothermal immunotherapy.
Dai Y; Zhu L; Li X; Zhang F; Chen K; Jiao G; Liu Y; Yang Z; Guo Z; Zhang B; Shen Q; Zhao Q
Biomaterials; 2024 Mar; 305():122455. PubMed ID: 38160626
[TBL] [Abstract][Full Text] [Related]
14. A multi-mode Rhein-based nano-platform synergizing ferrotherapy/chemotherapy-induced immunotherapy for enhanced tumor therapy.
Zhu X; Xie L; Tian J; Jiang Y; Song E; Song Y
Acta Biomater; 2024 May; 180():383-393. PubMed ID: 38570106
[TBL] [Abstract][Full Text] [Related]
15. Enzyme Core Spherical Nucleic Acid That Enables Enhanced Cuproptosis and Antitumor Immune Response through Alleviating Tumor Hypoxia.
Huang Y; Liu X; Zhu J; Chen Z; Yu L; Huang X; Dong C; Li J; Zhou H; Yang Y; Tan W
J Am Chem Soc; 2024 May; 146(20):13805-13816. PubMed ID: 38552185
[TBL] [Abstract][Full Text] [Related]
16. An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy.
Xu Y; Liu SY; Zeng L; Ma H; Zhang Y; Yang H; Liu Y; Fang S; Zhao J; Xu Y; Ashby CR; He Y; Dai Z; Pan Y
Adv Mater; 2022 Oct; 34(43):e2204733. PubMed ID: 36054475
[TBL] [Abstract][Full Text] [Related]
17. Dendrimer/metal-phenolic nanocomplexes encapsulating CuO
Huang H; Guo H; Liu J; Ni C; Xia L; Cao X; Xia J; Shi X; Guo R
Acta Biomater; 2024 May; ():. PubMed ID: 38801869
[TBL] [Abstract][Full Text] [Related]
18. Inhalable metal-organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy.
Yan C; Liu Y; Zhao G; Yang H; Lv H; Li G; Li Y; Fu Y; Sun F; Feng Y; Li Y; Zhao Z
Acta Pharm Sin B; 2024 May; 14(5):2281-2297. PubMed ID: 38799628
[TBL] [Abstract][Full Text] [Related]
19. Renal Clearable Ultrasmall Single-Crystal Fe Nanoparticles for Highly Selective and Effective Ferroptosis Therapy and Immunotherapy.
Liang H; Wu X; Zhao G; Feng K; Ni K; Sun X
J Am Chem Soc; 2021 Sep; 143(38):15812-15823. PubMed ID: 34473493
[TBL] [Abstract][Full Text] [Related]
20. A Self-Amplifying ROS-Responsive Nanoplatform for Simultaneous Cuproptosis and Cancer Immunotherapy.
Wu H; Zhang Z; Cao Y; Hu Y; Li Y; Zhang L; Cao X; Wen H; Zhang Y; Lv H; Jin X
Adv Sci (Weinh); 2024 Jun; 11(23):e2401047. PubMed ID: 38569217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
